Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients
NACompletedINTERVENTIONAL
Enrollment
200
Participants
Timeline
Start Date
January 31, 2005
Study Completion Date
December 31, 2008
Conditions
Gastroesophageal RefluxLaryngitis
Interventions
DRUG
Rabeprazole 20mg twice daily
Trial Locations (1)
Unknown
Queen Mary Hospital, Hong Kong
All Listed Sponsors
collaborator
The University of Hong Kong
OTHER
lead
Hospital Authority, Hong Kong
OTHER_GOV
NCT00517114 - Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients | Biotech Hunter | Biotech Hunter